# A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

> **NCT06731829** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 78 (estimated)

## Conditions studied

- For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions

## Interventions

- **DRUG:** HRS-9231
- **DRUG:** Gadobutrol

## Key facts

- **NCT ID:** NCT06731829
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731829, "A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06731829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*